Get started
Author

Piergiuseppe Zagnoni

Observed names: P Zagnoni, P. G. Zagnoni, P. Zagnoni, P.G. Zagnoni, P. G. Zagnoni, ZAGNONI P. G, Zagnoni Piergiuseppe
OpenAlex ID: A5079314325
Psychostimulants and Epilepsy
2002 · P. G. Zagnoni, C. Albano · Epilepsia · 108
PDF
Conventional vs controlled-release carbamazepine: a multicentre, double-blind, cross-over study
2009 · R. Canger, A. C. Altamura, et al. · Acta Neurologica Scandinavica · 62
Allopurinol as Add‐on Therapy in Refractory Epilepsy: A Double‐Blind Placebo‐Controlled Randomized Study Italy, on his retirement.
1994 · P. G. Zagnoni, A. Bianchi, et al. · Epilepsia · 43
Oxiracetam in the Treatment of Primary Degenerative and Multi-Infarct Dementia: A Double-Blind, Placebo-Controlled Study
2008 · G. Maina, L. Fiori, et al. · Neuropsychobiology · 34
Plasma levels of di-no-propylacetate and clonazepam in epileptic patients.
1977 · A Baruzzi, B Bordo, et al. · PubMed · 20
Allopurinol and severe epilepsy
1986 · Pasquale DeMarco, Piergiuseppe Zagnoni · Neurology · 18
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia
2020 · Alessandro Morandi, Antonella Zambon, et al. · Journal of the American Medical Directors Association · 17
Allopurinol as add-on therapy in refractory epilepsy: a double blind-placebo controlled, randomized study
1991 · P. Zagnoni, A Bianchi, et al. · BOA (University of Milano-Bicocca) · 11
Predictive performance of pharmacokinetic methods for phenytoin dosing: a multi-center evaluation in 282 patients with epilepsy
1989 · G Zaccara, A Messori, et al. · Epilepsy Research · 9
Single photon emission computed tomography with99mTc HM-PAO in the study of focal epilepsy
1989 · E. Grasso, L. Ambrogio, et al. · Neurological Sciences · 6
Epileptic seizures and lipoma of the corpus callosum
1982 · E. Grasso, P. C. Gerbino Promis, et al. · Neurological Sciences · 3
[Evaluation of the efficacy and tolerability of fluoxetine in major depression, Multicenter clinical study].
1991 · P L Cabras, E Enriques, et al. · PubMed · 1
Preclinical phase of Alzheimer's disease: Guideline for recognition and study of patients with mild cognitive impairment
2002 · Carlo Caltagirone, Roberta Perri, et al. · Nova Science Publishers (Nova Science Publishers, Inc.)
Laotrigine serum level monitoring in clinical practice
1997 · P. Zagnoni, S. Giubergia, et al. · CINECA IRIS Institutial Research Information System (University of Genoa)
Studio prospettico randomizzato sull'impatto clinico del monitoraggio terapeutico dei farmaci antiepilettici in pazienti con epilessia di recente diagnosi: Valutazione ad interim
1996 · E. Bottacchi, E. Carenini, et al. · Bollettino - Lega italiana contro l'epilessia
Allopurinol as add-on therapy in refractory epilepsy: a double-blind placebo-controlled randomized study.
1994 · ZAGNONI P. G, BIANCHI A, et al. · Institutional Research Information System University of Turin (University of Turin)
Use of plasma levels for antiepileptic drug monitoring in clinical practice
1992 · Gruppo Collaborativo per lo Studio dell'Epilessia, E. Beghi, et al. · The Italian Journal of Neurological Sciences
Conventional vs controlled-release CBZ : A multicentre, double-blind, cross-over study
1988 · R. Canger, Daniela Belvedere, et al.
Allopurinol and epilepsy
1987 · Pasquale De Marco, Piergiuseppe Zagnoni · Neurology
Sulphinpyrazone dose schedule in hyperuricemic patients with cardiovascular diseases: tolerability assessment
1985 · Bertoli Livic, Busnardo Ines, et al. · Pharmacological Research Communications
[Frequency of risk factors in cerebrovascular disease and their effect on the course and outcome. Study on 423 hospitalized patients].
1981 · A Cognazzo, E Grasso, et al. · PubMed
[Plasma levels of anti-epileptic drugs. Evaluation of determinations carried out in the years 1978-1979].
1981 · P Zagnoni, A Cognazzo, et al. · PubMed
Literature Abstracts
1979 · A Baruzzi, B Bordo, et al. · Therapeutic Drug Monitoring
Works count: 23
Citation count: 332
H-index: 9
I10-index: 8
Year
Topic
Type